CVS beats estimates, but cuts full-year profit outlook on higher medical costs

[Collection]CVS beats estimates, but cuts full-year profit outlook on higher medical costsThe company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from previous guidance of at least $8.50 per share.https://www.cnbc.com/2024/02/07/cvs-heath-cvs-q4-2023-earnings.html2024-02-07T11:31:00.000Z